Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 3
1996 1
1997 1
2001 4
2002 6
2003 5
2004 10
2005 4
2006 5
2007 9
2008 12
2009 14
2010 13
2011 9
2012 12
2013 12
2014 10
2015 8
2016 10
2017 7
2018 7
2019 8
2020 19
2021 12
2022 9
2023 6
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

188 results

Results by year

Filters applied: . Clear all
Page 1
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes.
Frías JP, Davies MJ, Rosenstock J, Pérez Manghi FC, Fernández Landó L, Bergman BK, Liu B, Cui X, Brown K; SURPASS-2 Investigators. Frías JP, et al. N Engl J Med. 2021 Aug 5;385(6):503-515. doi: 10.1056/NEJMoa2107519. Epub 2021 Jun 25. N Engl J Med. 2021. PMID: 34170647 Clinical Trial.
Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease.
Bhatt DL, Szarek M, Pitt B, Cannon CP, Leiter LA, McGuire DK, Lewis JB, Riddle MC, Inzucchi SE, Kosiborod MN, Cherney DZI, Dwyer JP, Scirica BM, Bailey CJ, Díaz R, Ray KK, Udell JA, Lopes RD, Lapuerta P, Steg PG; SCORED Investigators. Bhatt DL, et al. N Engl J Med. 2021 Jan 14;384(2):129-139. doi: 10.1056/NEJMoa2030186. Epub 2020 Nov 16. N Engl J Med. 2021. PMID: 33200891 Clinical Trial.
Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial.
Del Prato S, Kahn SE, Pavo I, Weerakkody GJ, Yang Z, Doupis J, Aizenberg D, Wynne AG, Riesmeyer JS, Heine RJ, Wiese RJ; SURPASS-4 Investigators. Del Prato S, et al. Lancet. 2021 Nov 13;398(10313):1811-1824. doi: 10.1016/S0140-6736(21)02188-7. Epub 2021 Oct 18. Lancet. 2021. PMID: 34672967 Clinical Trial.
In-hospital care of children with COVID-19.
Chan OW, Lee EP, Chou CC, Lai SH, Chung HT, Lee J, Lin JJ, Hsieh KS, Hsia SH. Chan OW, et al. Among authors: hsia sh. Pediatr Neonatol. 2024 Jan;65(1):2-10. doi: 10.1016/j.pedneo.2023.02.009. Epub 2023 Oct 21. Pediatr Neonatol. 2024. PMID: 37989708 Free article. Review.
Enterovirus A71 neurologic complications and long-term sequelae.
Chang LY, Lin HY, Gau SS, Lu CY, Hsia SH, Huang YC, Huang LM, Lin TY. Chang LY, et al. Among authors: hsia sh. J Biomed Sci. 2019 Aug 8;26(1):57. doi: 10.1186/s12929-019-0552-7. J Biomed Sci. 2019. PMID: 31395054 Free PMC article. Review.
Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a/b trial.
Sanyal AJ, Lopez P, Lawitz EJ, Lucas KJ, Loeffler J, Kim W, Goh GBB, Huang JF, Serra C, Andreone P, Chen YC, Hsia SH, Ratziu V, Aizenberg D, Tobita H, Sheikh AM, Vierling JM, Kim YJ, Hyogo H, Tai D, Goodman Z, Schaefer F, Carbarns IRI, Lamle S, Martic M, Naoumov NV, Brass CA. Sanyal AJ, et al. Among authors: hsia sh. Nat Med. 2023 Feb;29(2):392-400. doi: 10.1038/s41591-022-02200-8. Epub 2023 Feb 16. Nat Med. 2023. PMID: 36797481 Free PMC article. Clinical Trial.
The endocrine effects of nicotine and cigarette smoke.
Tweed JO, Hsia SH, Lutfy K, Friedman TC. Tweed JO, et al. Among authors: hsia sh. Trends Endocrinol Metab. 2012 Jul;23(7):334-42. doi: 10.1016/j.tem.2012.03.006. Epub 2012 May 2. Trends Endocrinol Metab. 2012. PMID: 22561025 Free PMC article. Review.
Non-HDL cholesterol: into the spotlight.
Hsia SH. Hsia SH. Diabetes Care. 2003 Jan;26(1):240-2. doi: 10.2337/diacare.26.1.240. Diabetes Care. 2003. PMID: 12502688 Review. No abstract available.
188 results